library as a tyrosinase-resistant tyrosine surrogate. Among
all of the known mono-, di-, and multiply fluorinated tyrosine
analogues, we reasoned that 3,5-difluorotyrosine (F2Y,
compound 1 in Scheme 1) should contain the minimal
phase by using standard Fmoc/HBTU chemistry (Table 1,
Table 1. Comparison of the Kinetic Constants of F2Y- and
Tyr-Containing Peptides against PTP1B (pH 7.4)
peptide
kcat (s-1 KM (µM) kcat/KM (µM-1 s-1
) )
Scheme 1. Synthesis of Fully Protected F2Y
DNLF2YpYWD-NH2 (4)
DNLYpYWD-NH2 (5)
DDTF2YDpYAA-NH2 (6) 36 ( 2
DDTYDpYAA-NH2 (7) 33 ( 1
REF2YEFpYAA-NH2 (8) 44 ( 2
REYEFpYAA-NH2 (9)
36 ( 1 3.6 ( 0.4
32 ( 1 5.8 ( 0.8
10.0
5.5
2.7
2.3
3.2
5.4
13 ( 3
14 ( 2
14 ( 2
33 ( 1 6.0 ( 0.7
compounds 4-9). Peptide 5 is derived from a known pY
motif of receptor protein tyrosine kinase erbB2,11 whereas
peptides 7 and 9 are analogous to the prefered substrates of
PTP1B (the prototypical PTP), previously identified from a
peptide library.8 These peptides contain F2Y (or Tyr) at the
pY-3, pY-2, or pY-1 position (relative to pY, which is
designated as position 0). Earlier studies have shown that
residues at the N-terminal side of pY are most critical in
defining the substrate specificity of PTPs.12 During peptide
synthesis, NR-Fmoc-F2Y(tBu)-OH was efficiently incorpo-
rated into peptides without incidence (as judged by ninhydrin
tests), despite that it was used at only 1.5 equiv (4 equiv
was used for all other amino acids). Reversed-phase HPLC
analysis of the crude peptides showed that in each case the
desired peptide was the major product (see Figure 1, for
number of fluorine substitutions to render it resistant to
tyrosinase action. Because F and H atoms have similar van
der Waals radii (1.35 Å for F and 1.10 Å for H), Tyr and
F2Y are essentially isosteric, although the side chain of F2Y
has a lower pKa value (7.2) than that of Tyr (9.9).9
F2Y has previously been synthesized both chemically10
and enzymatically.3,4,7 Synthesis of F2Y-containing peptides
employed side chain unprotected Fmoc-F2Y-OH, and the
resulting peptides were purified by HPLC.4,7 The reported
peptides were either very short or contained F2Y near their
N-termini (therefore no repeated coupling reactions after
incorporation of F2Y), and each contained only a single F2Y
residue. We felt that the unprotected F2Y side chain might
be problematic with peptide library synthesis, during which
more forcing coupling conditions are typically employed to
drive reactions to completion, some library members will
contain multiple F2Y residues, and HPLC purification is not
an option. In this report, we describe the synthesis of fully
protected F2Y, its incorporation into peptides and peptide
libraries, and its activity against PTPs in comparison with
the tyrosine counterparts.
Figure 1. HPLC analysis of peptide 4 on a C-18 column, eluted
with a linear gradient of 10-60% CH3CN in H2O containing 0.1%
We employed the enzymatic systhesis originally developed
by Phillips and co-workers3 to prepare multigram quantities
of F2Y from 2,6-difluorophenol, pyruvate, and NH3 (Scheme
1). Treatment of F2Y with N-(9-fluorenylmethylcarbonylox-
y)succinimide in 10% sodium carbonate gave NR-Fmoc-F2Y-
OH, which was subsequently converted into its methyl ester
2 using thionyl chloride in refluxing methanol. The phenol
group was next protected as a tert-butyl ether by treatment
with isobutylene and H2SO4. Finally, hydrolysis of the methyl
ester by LiOH in THF/H2O gave the desired NR-Fmoc-
F2Y(tBu)-OH (3) in 24% overall yield (from F2Y).
trifluoroacetic acid over 50 min.
example). Peptides 4-9 were purified by preparative HPLC,
and their kinetic activities toward PTP1B (i.e., kcat, KM, and
kcat/KM values) were determined at pH 7.4 (Table 1). The
data show that substitution of F2Y for tyrosine resulted in
minimal changes in kinetic constants (e2-fold, which is
within the margin of experimental error). Thus, F2Y is a good
functional mimic of tyrosine, in terms of binding to the active
site of PTPs.
Three F2Y-containing peptides and their corresponding
Tyr-containing counterparts were synthesized on the solid
(11) Yamamoto, T.; Ikawa, S.; Akiyama, T.; Nomura, N.; Miyajima,
N.; Saito, T.; Toyoshima, K. Nature 1986, 319, 230–234.
(12) (a) Zhang, Z.-Y.; Thieme-Sefler, A. M.; Maclean, D.; McNamara,
D. J.; Dobrusin, E. M.; Sawyer, T. M.; Dixon, J. E. Proc. Natl. Acad. Sci.
U.S.A. 1993, 90, 4446–4450. (b) Zhang, Z.-Y.; Maclean, D.; McNamara,
D. J.; Sawyer, T. K.; Dixon, J. E. Biochemistry 1994, 33, 2285–2290.
(9) Seyedsayamdost, M. R.; Reece, S. Y.; Nocera, D. G.; Stubbe, J.
J. Am. Chem. Soc. 2006, 128, 1569–1579.
(10) Kirk, K. L. J. Org. Chem. 1980, 45, 2015–2016.
4606
Org. Lett., Vol. 10, No. 20, 2008